Source: BioPortfolio

Transdermal Delivery Solutions: TD Solutions Announces Levellor HypoSpray Insulin

TD Solutions a leader in the development of sprayon pharmaceuticals SOP announced today they have initiated product development for a needlefree Human Insulin product TD Solutions announced today that they have initiated developm...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250